KROS
Keros Therapeutics, Inc.Healthcare$12.00
◆ Neutral
Mkt Cap: $365.6M|Float: 19.2M|SI: 10.4%|DTC: 4.5
Data as of market close Apr 2, 2026
IV Rank
-
IV Pctl
-
HV 20d
48.3%
52W Range
$9-$23
ATR(14)
$0.58
Exp. Move
±14.4%
P/C Ratio
1.55
Earnings
May 11
GEX Positive
DEX Long
Net Call Premium
Max Pain Below
Exp. Move Wide
High Put/Call
KROS Key Options Data
- Total GEX
- $0.00B
- Total DEX
- $0.3M
- Max Pain
- $10.00
- Expected Move
- ±14.4%
- Put/Call OI
- 1.55
- Net Premium
- $0.6M
- Spot Price
- $12.00
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.73 | ±14.4% | $10.28 | $13.72 |
| 2026-06-18 | 77 | ±$8.30 | ±69.2% | $3.70 | $20.30 |
| 2026-09-18 | 169 | ±$2.85 | ±23.8% | $9.15 | $14.85 |
Explore KROS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.